Fortnightly review - Update on male erectile dysfunction

被引:71
作者
Wagner, G [1 ]
de Tejada, IS
机构
[1] Univ Copenhagen, Panum Inst, DK-2200 Copenhagen N, Denmark
[2] Hosp Ruber Int, Androl Unit, Urol Serv, Madrid, Spain
来源
BMJ-BRITISH MEDICAL JOURNAL | 1998年 / 316卷 / 7132期
关键词
D O I
10.1136/bmj.316.7132.678
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:678 / 682
页数:5
相关论文
共 41 条
[31]  
MEINHARDT W, 1996, INT J IMPOT RES, V8, P116
[32]  
MORALES A, 1995, UROL CLIN N AM, V165, P60
[33]   ASSESSMENT AND TREATMENT OF IMPOTENCE [J].
OKEEFE, M ;
HUNT, DK .
MEDICAL CLINICS OF NORTH AMERICA, 1995, 79 (02) :415-434
[34]   Treatment of men with erectile dysfunction with transurethral alprostadil [J].
PadmaNathan, H ;
Hellstrom, WJG ;
Kaiser, FE ;
Labasky, RF ;
Lue, TF ;
Nolten, WE ;
Norwood, PC ;
Peterson, CA ;
Shabsigh, R ;
Tam, PY ;
Place, VA ;
Gesundheit, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (01) :1-7
[35]   NITRIC-OXIDE RELEASE ACCOUNTS FOR THE BIOLOGICAL-ACTIVITY OF ENDOTHELIUM-DERIVED RELAXING FACTOR [J].
PALMER, RMJ ;
FERRIGE, AG ;
MONCADA, S .
NATURE, 1987, 327 (6122) :524-526
[36]  
REID K, 1987, LANCET, V2, P421
[37]   IMPOTENCE AND DIABETES MELLITUS [J].
RUBIN, A ;
BABBOTT, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1958, 168 (05) :498-500
[38]  
*TOMHS RES GROUP, 1996, EUR UROL S2, V30, P38
[39]  
WAGNER G, 1994, INT J IMPOT RES S1, V6, pD78
[40]  
Wagner G., 1981, IMPOTENCE PHYSL PSYC